Clearmind Medicine Inc. Cash Flows From Used In Decrease Increase In Restricted Cash And Cash Equivalents
Clearmind Medicine Inc. (CMND) reported Cash Flows From Used In Decrease Increase In Restricted Cash And Cash Equivalents of -$13.50 thousand for the 12-month period ending 2025-10-31, per its 20-F filed 2026-01-20.
Financial Statements › Notes
ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInRestrictedCashAndCashEquivalents · last filed 2026-03-12
CAD
| Period end | Cash Flows From Used In Decrease Increase In Restricted Cash And Cash Equivalents 12 month |
|---|---|
| 2021-10-31 | -20.00K CAD 20-F · filed 2023-02-06 |
USD
| Period end | Cash Flows From Used In Decrease Increase In Restricted Cash And Cash Equivalents 3 month | Cash Flows From Used In Decrease Increase In Restricted Cash And Cash Equivalents 6 month | Cash Flows From Used In Decrease Increase In Restricted Cash And Cash Equivalents 9 month | Cash Flows From Used In Decrease Increase In Restricted Cash And Cash Equivalents 12 month |
|---|---|---|---|---|
| 2025-10-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | $0.00 derived: sum of 2 quarters · filed 2026-01-20 | $0.00 derived: sum of 3 quarters · filed 2026-01-20 | -$13.50K 20-F · filed 2026-01-20 |
| 2025-07-31 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2025-09-11 | $0.00 derived: sum of 2 quarters · filed 2025-09-11 | -$13.50K 6-K · filed 2025-09-11 | -$13.50K derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-04-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2025-06-12 | -$13.50K 6-K · filed 2025-06-12 | -$13.50K derived: sum of 3 quarters · filed 2026-03-12 | |
| 2025-01-31 | -$13.50K 6-K · filed 2026-03-12 | -$13.50K derived: sum of 2 quarters · filed 2026-03-12 | ||
| 2024-10-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | $33.80K 20-F · filed 2026-01-20 | ||
| 2024-07-31 | $33.80K 6-K · filed 2025-09-11 | |||
| 2023-10-31 | -$33.91K derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | -$26.23K 20-F · filed 2026-01-20 | ||
| 2023-07-31 | $7.69K 6-K · filed 2024-09-16 | |||
| 2021-10-31 | -$14.65K 20-F/A · filed 2024-03-18 |